NIH Guide for Grants and Contracts
October 25, 2019
Weekly NIH Funding Opportunities and Notices

General Notices

Notice of Changes to Funding Opportunities

Notices of Intent to Publish

Notices of Special Interest

Funding Opportunities

  • Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Optional)
    (PAR-20-036)
    National Institute of Allergy and Infectious Diseases
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute of Mental Health
    Application Receipt Date(s): Only accepting applications for the AIDS Application Due Dates listed below.

  • Support of Competitive Research (SCORE) Research Advancement Award (SC1 - Clinical Trial Not Allowed)
    (PAR-20-039)
    National Institute of General Medical Sciences
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): January 25, 2020; May 25, 2020; January 25, 2021; May 25, 2021; January 25, 2022; May 25, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Support of Competitive Research (SCORE) Pilot Project Award (SC2 - Clinical Trial Not Allowed)
    (PAR-20-040)
    National Institute of General Medical Sciences
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): January 25, 2020; May 25, 2020; January 25, 2021; May 25, 2021; January 25, 2022; May 25, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Support of Competitive Research (SCORE) Research Continuance Award (SC3 - Clinical Trial Not Allowed)
    (PAR-20-041)
    National Institute of General Medical Sciences
    National Institute of Allergy and Infectious Diseases
    National Institute on Deafness and Other Communication Disorders
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): January 25, 2020; May 25, 2020; January 25, 2021; May 25, 2021; January 25, 2022; May 25, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • NCMRR Early Career Research Award (R03 Clinical Trial Optional)
    (PAR-20-042)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): March 30, 2020, March 30, 2021, March 30, 2022

  • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease and Related Dementias (AD/ADRD) (R61/R33 Clinical Trials Optional)
    (RFA-AG-20-026)
    National Institute on Aging
    Application Receipt Date(s): February 3, 2020, by 5:00 PM local time of applicant organization. All applications allowed for this funding opportunity announcement are due on thisdate. No late applications will be accepted for this Funding Opportunity Announcement.

  • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not Allowed)
    (RFA-AG-20-027)
    National Institute on Aging
    Application Receipt Date(s): February 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will accepted for this funding opportunity announcement.

  • Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network (NCTN)(U24 Clinical Trial Not Allowed)
    (RFA-CA-20-002)
    National Cancer Institute
    Application Receipt Date(s): December 17, 2019 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

  • Identification, Validation, and Manipulation of Neural Circuits Related to Mental Illness and Alcohol and Substance Use Disorders in Non-human Primates (R01 Clinical Trial Not Allowed)
    (RFA-MH-20-320)
    National Institute of Mental Health
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Drug Abuse
    Application Receipt Date(s): February 10, 2020 No late applications will be accepted for this Funding Opportunity Announcement.

  • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
    (RFA-TR-20-001)
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): February 6, 2020, October 6, 2020, and October 6, 2021